Targeting HIF1α/AP1 in hypoxia by novel 7-amino-6-halogeno-3-phenylquinoxaline-2-carbonitrile 1,4-dioxides von Scherbakov, A M, Buravchenko, G I, Dezhenkova, L G, Shchekotikhin, A E

Volltext

Development of a Parenteral Medicinal Formulation of the New Antifungal Semisynthetic Polyene Antibiotic Amphamide von Tevyashova, A. N., Bychkova, E. N., Solov’eva, S. E., Grammatikova, N. É., Shchekotikhin, A. E.

Volltext

Development of a Dosage Form of the New Antitumor Antibiotic Olivamide von Tevyashova, A. N., Bychkova, E. N., Dezhenkova, L. G., Shchekotikhin, A. E.

Volltext

PO-458 The role of functional groups in the antitumor properties of antrafuran von Shchekotikhin, A, Tikhomirov, A, Kaur, P, Shtil, A

Volltext

Preclinical Pharmacokinetic and Toxicity Studies of Anthrafuran – A New Antitumor Agent von Portnoi, Yu. A., Dovzhenko, S. A., Kobrin, M. B., Pereverzeva, E. R., Treshchalin, M. I., Golibrodo, V. A., Shchekotikhin, A. E., Firsov, A. A.

Volltext

Modified 5-fluorouracil: Uridine phosphorylase inhibitor von Lashkov, A. A., Shchekotikhin, A. A., Shtil, A. A., Sotnichenko, S. E., Mikhailov, A. M.

Volltext

56P tNOX and Sirt1 as potential targets of antitumor action of heliomycin derivatives von Tikhomirov, A., Chueh, P.J., Shchekotikhin, A.

Volltext

51P Targeting carbonic anhydrase IX with novel isatin-5-sulphonamides: A way forward to control tumour acidosis von Krymov, S., Scherbakov, A.M., Shchekotikhin, A.

Volltext

52P Novel inhibitors of androgen receptor with antiproliferative potency against hormone-sensitive and hormone-resistant breast cancer cells von Scherbakov, A.M., Krymov, S., Sorokin, D., Salnikova, D.I., Shchekotikhin, A.

Volltext

Sequencing and analysis of the resistome of Streptomyces fradiae ATCC19609 in order to develop a test system for screening of new antimicrobial agents von Vatlin, A. A., Bekker, O. B., Lysenkova, L. N., Korolev, A. M., Shchekotikhin, A. E., Danilenko, V. N.

Volltext

Ligands of G-quadruplex nucleic acids von Andreeva, D V, Tikhomirov, A S, Shchekotikhin, A E

Volltext

14P Modulation of MCF-7 cell sensitivity to anticancer agents by targeting glycolysis von Scherbakov, A.M., Sorokin, D., Omelchuk, O., Shchekotikhin, A., Krasil’nikov, M.

Volltext

Characterization of HERG potassium channel inhibition using CoMSiA 3D QSAR and homology modeling approaches von Pearlstein, Robert A, Vaz, Roy J, Kang, Jiesheng, Chen, Xiao-Liang, Preobrazhenskaya, Maria, Shchekotikhin, Andrey E, Korolev, Alexander M, Lysenkova, Ludmila N, Miroshnikova, Olga V, Hendrix, James, Rampe, David

Volltext

77P Dual targeting oxidative phosphorylation and glycolysis in triple-negative breast cancers: En route to effective inhibition of tumour metabolism von Scherbakov, A.M., Omelchuk, O., Sorokin, D., Shatskaya, V., Shchekotikhin, A., Krasil’nikov, M.

Volltext

44P Novel insights into the pharmacological effects of hypoxic cytotoxins in hormone-dependent breast cancer cells: ERα degradation and modulation of ERK signaling activity von Scherbakov, A.M., Buravchenko, G., Sorokin, D., Monzote Fidalgo, L., Shchekotikhin, A.

Volltext

60P - Sensitization of estrogen receptor-positive breast cancer cells to tamoxifen by novel epi-oligomycin A von Yastrebova, M.A., Omelchuk, O., Lysenkova, L., Mikhaevich, E., Scherbakov, A.M., Shchekotikhin, A.

Volltext

Sensitization of estrogen receptor-positive breast cancer cells to tamoxifen by novel epi-oligomycin A von Yastrebova, M.A., Omelchuk, O., Lysenkova, L., Mikhaevich, E., Scherbakov, A.M., Shchekotikhin, A.

Volltext

60PSensitization of estrogen receptor-positive breast cancer cells to tamoxifen by novel epi-oligomycin A von Yastrebova, M A, Omelchuk, O, Lysenkova, L, Mikhaevich, E, Scherbakov, A M, Shchekotikhin, A

Volltext

12PTargeting HIF1α/AP1 in hypoxia by novel 7-amino-6-halogeno-3-phenylquinoxaline-2-carbonitrile 1,4-dioxides von Scherbakov, A M, Buravchenko, G I, Dezhenkova, L G, Shchekotikhin, A E

Volltext

Nikolai Nikolaevich Suvorov (1922-1999) on the ninetieth anniversary of his birth von Buyanov, V.N, Shchekotikhin, A.E

Volltext